Induction of drug-metabolizing enzymes by tricyclic antidepressants in human liver: characterization and partial resolution of cytochromes P-450

Br J Clin Pharmacol. 1983 Dec;16(6):651-7. doi: 10.1111/j.1365-2125.1983.tb02236.x.

Abstract

Drug-metabolizing enzyme activities were determined in liver microsomes from six kidney-transplant donors, one tricyclic antidepressant-treated and five untreated donors. The tricyclic antidepressant treatment modifies neither the overall cytochrome P-450 content of the liver, nor enzymatic activities of 4-nitroanisole demethylase, aniline hydroxylase, epoxide hydrolase and glutathione S-transferase. Only benzphetamine and ketotifen demethylation and conjugation of bilirubin with UDP-glucuronic acid are markedly augmented (more than two-fold). Separation of the different cytochrome P-450 fractions on a DEAE cellulose column indicates a modification of the elution pattern: the fraction increased by tricyclic antidepressants is responsible for the enhanced monooxygenase activity towards benzopyrene and benzphetamine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antidepressive Agents, Tricyclic / pharmacology*
  • Cytochrome P-450 Enzyme System / biosynthesis*
  • Cytochrome P-450 Enzyme System / isolation & purification
  • Enzyme Induction / drug effects
  • Female
  • Humans
  • Liver / enzymology*
  • Male
  • Pharmaceutical Preparations / metabolism*

Substances

  • Antidepressive Agents, Tricyclic
  • Pharmaceutical Preparations
  • Cytochrome P-450 Enzyme System